Gene: Cited1 (Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1) Rattus norvegicus
Analyze
Symbol: Cited1
Name: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
Description: Predicted to have several functions, including LBD domain binding activity, chromatin binding activity, and co-SMAD binding activity; involved in several processes, including branching involved in ureteric bud morphogenesis, embryonic axis specification, and regulation of cellular biosynthetic process; localizes to the cytoplasm; orthologous to human CITED1 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1); INTERACTS WITH aflatoxin B1; ammonium chloride; bisphenol A.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: cbp/p300-interacting transactivator 1; melanocyte-specific gene 1 protein; Msg1
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0X72,128,996 - 72,133,692 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0X72,970,882 - 72,975,577 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4X90,301,067 - 90,305,762 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.1X90,374,502 - 90,379,195 (-)NCBI
CeleraX67,703,821 - 67,708,586 (-)NCBICelera
Cytogenetic MapXq22NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Cited1
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 620781
Created: 2002-08-06
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.